Key Market Segments:
By Type
-
-
Viral Vector Platforms
-
Adeno-associated Virus (AAV)
-
Lentivirus
-
Retrovirus
-
Adenovirus
-
Herpes Simplex Virus (HSV)
-
-
Non-Viral Vector Platforms
-
Lipid Nanoparticles (LNPs)
-
Electroporation & Microinjection Platforms
-
Polymer-based Delivery Systems
-
Naked DNA/RNA Delivery
-
-
Gene Editing Platforms
-
CRISPR-Cas Systems
-
TALENs
-
ZFNs
-
-
By Application
-
-
Oncology
-
Rare Genetic Disorders
-
Cardiovascular Diseases
-
Neurological Disorders
-
Ophthalmic Diseases
-
Hematological Disorders (e.g., Hemophilia, Sickle Cell)
-
Musculoskeletal Disorders
-
Infectious Diseases (e.g., HIV, COVID-19 adjunct therapies)
-
By Delivery Mode
-
-
In Vivo Gene Therapy
-
Ex Vivo Gene Therapy
-
Autologous Cell-Based Gene Therapy
-
Allogeneic Cell-Based Gene Therapy
-
-
Others (In-situ Gene therapy)
-
By End Use
-
-
Pharmaceutical & Biotechnology Companies
-
Academic & Research Institutions
-
Contract Development & Manufacturing Organizations (CDMOs)
-
Hospitals & Gene Therapy Centers
-
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Turkey
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the Gene Therapy Platform Market in 2024
The “Oncology” segment dominated the Gene Therapy Platform Market.
The Increasing incidence of genetic and rare diseases is driving market growth.
The Gene Therapy Platform Market was USD 2.38 billion in 2024 and is expected to reach USD 7.50 billion by 2032.
The Gene Therapy Platform Market is expected to grow at a CAGR of 15.51% from 2025 to 2032.